D-cycloserine Augmented CBT for Panic Disorder

Phase 3 Terminated 33 enrolled University of Oxford Medical Research Council · collab

RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of this study is to determine whether d-cycloserine augments the clinical effects of exposure-based cognitive-behaviour therapy for panic disorder.

Timeline

Start: 2012-10
Primary completion: 2017-10-31
Completion: 2018-04-30

Publications

Reinecke A, Nickless A, Browning M, Harmer CJ. Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial. Behav Res Ther. 2020 Jun;129:103607. doi: 10.1016/j.brat.2020.103607. Epub 2020 Mar 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cycloserine	Small molecule	250 mg	Oral

D-cycloserine Augmented CBT for Panic Disorder

Summary

Timeline

Publications

Drugs

Indications